BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 5734763)

  • 1. [Biochemical findings in osteogenesis imperfecta].
    Mühlbach R
    Beitr Orthop Traumatol; 1968 Oct; 15(10):635-6. PubMed ID: 5734763
    [No Abstract]   [Full Text] [Related]  

  • 2. [Osteogenesis imperfecta tarda].
    Janssen G
    Z Orthop Ihre Grenzgeb; 1973 Aug; 111(4):592-3. PubMed ID: 4131007
    [No Abstract]   [Full Text] [Related]  

  • 3. Decrease of serum alkaline phosphatase after three cycles of pamidronate disodium in children with severe osteogenesis imperfecta.
    Cabral de Menezes Filho H; Rodrigues JM; Radonsky V; Della Manna T; Kuperman H; Steinmetz L; Dichtchekenian V; Damiani D; Setian N
    Horm Res; 2007; 68 Suppl 5():207-8. PubMed ID: 18174750
    [No Abstract]   [Full Text] [Related]  

  • 4. Enzyme histochemical localisation of alkaline phosphatase activity in osteogenesis imperfecta bone and growth plate: a preliminary study.
    Sarathchandra P; Cassella JP; Ali SY
    Micron; 2005; 36(7-8):715-20. PubMed ID: 16182549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma osteocalcin levels in patients with osteogenesis imperfecta.
    Castells S; Yasumura S; Fusi MA; Colbert C; Bachtell RS; Smith S
    J Pediatr; 1986 Jul; 109(1):88-91. PubMed ID: 3487629
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta.
    DiMeglio LA; Ford L; McClintock C; Peacock M
    Bone; 2004 Nov; 35(5):1038-45. PubMed ID: 15542028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in bone biochemical markers after high-dose cerivastatin treatment in a woman with osteogenesis imperfecta.
    Sugiyama T; Kawai S
    J Bone Miner Metab; 2001; 19(6):382-4. PubMed ID: 11685655
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biochemical studies of the serum of an infant with osteogenesis imperfecta].
    Maszewska-Kuźniarz K; Lukas A; Lukas W
    Wiad Lek; 1972 Feb; 25(4):379-82. PubMed ID: 5061599
    [No Abstract]   [Full Text] [Related]  

  • 9. [A contribution to the clinical picture of osteogenesis imperfecta].
    Janke D
    Beitr Orthop Traumatol; 1968 Oct; 15(10):634-5. PubMed ID: 5734762
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biochemical studies on osteogenesis imperfecta].
    Bethge JF; Tölke M; Wiesinger H
    Bruns Beitr Klin Chir (1971); 1967 Jun; 214(4):448-58. PubMed ID: 5593463
    [No Abstract]   [Full Text] [Related]  

  • 11. [Osteogenesis imperfecta with ketone hyperglycinemia, hyperserinemia and hyperornithinemia].
    Mechelany-Leroy L; Merckx J
    Nouv Presse Med; 1980 Jun; 9(26):1844. PubMed ID: 6771747
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum acid phosphatase in osteogenesis imperfecta.
    JACOBSEN JG; MATIENZO JA; FORBES AP; ROURKE GM
    Metabolism; 1961 Jun; 10():483-8. PubMed ID: 13718588
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies of patients with osteogenesis imperfecta.
    Albright JA; Grunt JA
    J Bone Joint Surg Am; 1971 Oct; 53(7):1415-25. PubMed ID: 5114704
    [No Abstract]   [Full Text] [Related]  

  • 14. Vitamin D and related research in osteogenesis imperfecta.
    Sbyrakis S; Mengreli C; Côté GB; Morakis A
    Prog Clin Biol Res; 1982; 104():367-76. PubMed ID: 6298814
    [No Abstract]   [Full Text] [Related]  

  • 15. Cortical bone dynamics measured by means of tetracycline labeling in 21 cases of osteoporosis.
    Villanueva A; Frost H; Ilnicki L; Frame B; Smith R; Arnstein R
    J Lab Clin Med; 1966 Oct; 68(4):599-616. PubMed ID: 5923251
    [No Abstract]   [Full Text] [Related]  

  • 16. [On fragilitas ossium hereditaria or Lobstein's disease (observations on 2 cases)].
    Zappata A; Mazzi C
    Ann Laringol Otol Rinol Faringol; 1968; 67(1):50-61. PubMed ID: 5757201
    [No Abstract]   [Full Text] [Related]  

  • 17. Normal serum acid phosphatase levels in osteogenesis imperfecta.
    GINSBERG DM
    Ann Intern Med; 1962 Jan; 56():141-3. PubMed ID: 13898751
    [No Abstract]   [Full Text] [Related]  

  • 18. Alendronate treatment in osteogenesis imperfecta.
    Madenci E; Yilmaz K; Yilmaz M; Coskun Y
    J Clin Rheumatol; 2006 Apr; 12(2):53-6. PubMed ID: 16601536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D metabolism in osteogenesis imperfecta during calcitonin therapy.
    Nishi Y; Hyodo S; Yoshimitsu K; Sawano K; Yamaoka K; Seino Y; Usui T
    Pediatrics; 1984 Apr; 73(4):538-42. PubMed ID: 6546792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [OSTEOGENESIS IMPERFECTA CONGENITA. CLINICAL, PATHOLOGICAL AND HISTOCHEMICAL STUDY].
    SCHAJOWICZ F; LUBOVITSKY BL; ROSEMBERG L
    Arch Argent Pediatr; 1963; 59():73-9. PubMed ID: 14154215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.